A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61K 38/08 (2006.01) A61K 38/25 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2600628
The invention is intended to simulate neuroregeneration of the central nervous system following autoimmune damage. More specifically, the invention relates to the pharmaceutical combination comprising therapeutically-effective concentrations of epidermal growth factor and human growth hormone secretagogue hexapeptide, which is administered to a patient suffering from the symptoms of multiple sclerosis and neuromyelitis optica and which corrects demyelination caused by autoreactive cells in the central nervous system.
La présente invention concerne la stimulation de la neurogénération du système nerveux central suite à une détérioration auto-immune. En particulier, la combinaison pharmaceutique renfermant des concentrations thérapeutiques efficaces du facteur de croissance épidermique et de l'hexapeptide sécrétagogue de l'hormone de croissance humaine est administrée à un patient souffrant de symptômes de sclérose en plaques et de neuromyélite optique et elle corrige la démyélinisation provoquée par des cellules autoréactives dans le système nerveux central.
Berlanga Acosta Jorge Amador
Cibrian Vera Danay
Freyre Almeida Freya de Los Milagros
Garcia Del Barco Herrera Diana
Guillen Nieto Gerardo Enrique
Centro de Ingenieria Genetica Y. Biotecnologia
Deeth Williams Wall Llp
LandOfFree
Combination of egf/ghrp-6 for neurogeneration of central... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of egf/ghrp-6 for neurogeneration of central..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of egf/ghrp-6 for neurogeneration of central... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1621447